blood-brain barrier permeation nanoparticle ligand glutathione Alanine and targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood–brain model | Fluids and Barriers of the CNS Nanotechnology to Overcome Blood–Brain Barrier
Nanotechnology to Overcome BloodBrain Barrier Permeability and Damage in Neurodegenerative Diseases PMC BloodBrain Barrier Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience Targeting receptor ligand chemistry for drug delivery across blood brain barrier in brain diseases ScienceDirect Nanotechnology to Overcome BloodBrain Barrier Permeability and Damage in Neurodegenerative Diseases
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



